Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Pharmacology|July 18, 2015
Population Pharmacokinetics and Therapeutic Efficacy of Febuxostat in Patients with Severe Renal ImpairmentDaiki Hira, Yugo Chisaki, Satoshi Noda, et al.
Current Therapeutic Research, Clinical and Experimental|February 9, 2026
Facts and Issues of Submitting Applications (Public Knowledge-Based Applications) for Unapproved and Off-label Drugs With High Medical Needs in JapanAkiko Hinomura, Daisuke Obata, Jun Matsubayashi, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 25, 2018
Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropeniaYurie Katsube, Daiki Hira, Masayuki Tsujimoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 15, 2021
In Vitro Evidence of Potential Interactions between CYP2C8 and Candesartan Acyl-β-D-glucuronide in the LiverYurie Katsube, Masayuki Tsujimoto, Hiroyoshi Koide, et al.
International Journal of Clinical Oncology|July 4, 2026
Relationships of serum cabozantinib concentration with tumor response and adverse events in treatment of advanced renal cell carcinoma: observational exploratory prospective studyYutaro Doke, Satoshi Noda, Takuto Kusaba, et al.
Optics Express|July 14, 2016
Development of a large plano-elliptical neutron-focusing supermirror with metallic substratesShin Takeda, Yutaka Yamagata, Norifumi L Yamada, et al.
Biochimica Et Biophysica Acta|June 5, 2003
Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsionsMayumi Yamamoto, Shin-ya Morita, Michiko Kumon, et al.
Biological & Pharmaceutical Bulletin|May 2, 2017
Previous Dosage of Allopurinol Is a Strong Determinant of Febuxostat EfficacyHiroyoshi Koide, Daiki Hira, Masayuki Tsujimoto, et al.
Optics Express|October 19, 2017
Development of precision elliptic neutron-focusing supermirrorTakuya Hosobata, Norifumi L Yamada, Masahiro Hino, et al.
Cancer Chemotherapy and Pharmacology|April 30, 2021
Exploratory analysis of target concentration of lenvatinib in the treatment of hepatocellular carcinomaSatoshi Noda, Hiroya Iida, Takehide Fujimoto, et al.
Pageof 9